$JNJ Company News Johnson & Johnson shares dip on

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$JNJ Company News

Johnson & Johnson shares dip on cautious outlook 51 min ago - blogs.marketwatch.com
Plug Power rallies; Lorillard drops on Reynolds merger 10:40 a.m. Today - Angela Johnson
U.S. stocks swing as Yellen speaks 10:27 a.m. Today - Barbara Kollmeyer
Newscast: NBA wants to double TV fees 9:59 a.m. Today - MarketWatch
Johnson & Johnson tops forecasts, boosts outlook 7:57 a.m. Today - MarketWatch.com
Johnson & Johnson shares up 0.4% in premarket trade 7:51 a.m. Today - Tomi Kilgore
Johnson & Johnson sees full-year 2014 adjusted EPS of $5.85 to $5.92 7:50 a.m. Today - William L. Watts
Johnson & Johnson Q2 sales up 9.1% to $19.5 billion 7:49 a.m. Today - William L. Watts
Johnson & Johnson Q2 adjusted EPS $1.66 7:49 a.m. Today - William L. Watts
Johnson & Johnson Q2 EPS $1.51 vs. $1.33 a year earlier 7:47 a.m. Today - William L. Watts
The market in a minute: Earnings over politics 10:56 a.m. July 14, 2014 - The Trading Deck
Tech, bank earnings to test economic recovery 6:01 a.m. July 13, 2014 - Wallace Witkowski
Wal-Mart embracing smaller stores in growth strategy 4:05 a.m. July 8, 2014 - Shelly Banjo
How to buy momentum stocks without getting burned 9:22 a.m. July 7, 2014 - Jonathan Burton
What GM could gain from the recall of 29 million cars 4:54 a.m. July 4, 2014 - Tim Mullaney
Whistleblower to get millions for speaking up 8:00 a.m. June 25, 2014 - Al Lewis
Medtronic-Covidien deal raises the stakes in medical-device universe 11:49 a.m. June 16, 2014 - blogs.marketwatch.com
Medtronic, Covidien in $40 billion merger talks: WSJ 1:02 p.m. June 14, 2014 - Dana Cimilluca
Where oh where has the liquidity gone? Goldman Sachs has an answer 12:38 p.m. June 13, 2014 - blogs.marketwatch.com
Picking winners from the Dow 10:23 a.m. May 29, 2014 - The Trading Deck


Johnson & Johnson Beats on Q2 Earnings, Ups View Again - Analyst Blog 51 min ago - Zacks.com
Johnson & Johnson (JNJ) Falls Despite Earnings Beat, Strong Olysio Sales 10:41 a.m. Today - TheStreet.com
Daily State Of The Markets: Can Earnings Season Carry The Bulls To Higher Ground? 10:15 a.m. Today - Seeking Alpha
More Good News to Backstop Market - Ahead of Wall Street 10:14 a.m. Today - Zacks.com
Dow Today: JPMorgan Chase (JPM) Leads The Day Higher, Johnson & Johnson (JNJ) Lags 10:00 a.m. Today - TheStreet.com
J&J's Results Lifted by Hepatitis C Drug 9:28 a.m. Today - The Wall Street Journal Interactive Edition
UPDATE: Johnson & Johnson Posts Upbeat Q2 Earnings, Lifts Outlook 7:05 a.m. Today - benzinga.com
July 15 Premarket Briefing: 10 Things You Should Know 6:43 a.m. Today - TheStreet.com
Stryker Continues Growth Spree via Acquisitions - Analyst Blog 6:20 p.m. July 14, 2014 - Zacks.com
Roche Presents Encouraging Data on Cobimetinib - Analyst Blog 5:40 p.m. July 14, 2014 - Zacks.com
Sanofi's Dengue Vaccine Data Published - Analyst Blog 5:20 p.m. July 14, 2014 - Zacks.com
Will Johnson & Johnson (JNJ) Beat this Earnings Season? - Analyst Blog 4:45 p.m. July 14, 2014 - Zacks.com
Why You Should Be Buying The 5 Largest Dividend Aristocrats 4:38 p.m. July 14, 2014 - Seeking Alpha
World’s 10 Most Respected Brands 2:30 p.m. July 14, 2014 - 247WallSt.com
Shire Meets AbbVie for Acquisition Deal - Analyst Blog 2:18 p.m. July 14, 2014 - Zacks.com
Why Pharma Is Flocking to Inversions 1:53 p.m. July 14, 2014 - The Wall Street Journal Interactive Edition
Janssen seeks expanded label for Invega Sustenna 1:19 p.m. July 14, 2014 - Seeking Alpha
Will Johnson & Johnson Top the Whisper Number This Quarter? 12:01 p.m. July 14, 2014 - Wall St. Cheat Sheet
Recent Trades - June 2014 11:55 a.m. July 14, 2014 - Seeking Alpha
MannKind: Are These Top Big Pharma Companies Potential Partners? 10:15 a.m. July 14, 2014 - Seeking Alpha


The Hepatitis C Virus Drug-Treated Population in the G7 Markets Will Reach Nearly Half a Million Cases in 2016 10:00 a.m. Today - PR Newswire - PRF
Critical Alerts For Exelixis, Rocket Fuel, Netflix, Johnson & Johnson, and Achillion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Today - PR Newswire - PRF
Johnson & Johnson Reports 2014 Second-Quarter Results: 7:45 a.m. Today - PR Newswire - PRF
InvestorsObserver releases comments on Google, Johnson & Johnson, JP Morgan Chase, eBay, and KB Home 9:31 a.m. July 14, 2014 - PR Newswire - PRF
USHCC Applauds Johnson & Johnson for Joining President Obama's Supply Chain Initiative 8:56 p.m. July 11, 2014 - GlobeNewswire
Electrophysiology Devices Market (ECG, EEG, Holter Monitoring Systems, Diagnostic Electrophysiology Catheters, Pacemaker, Imaging and 3D Mapping Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 12:34 p.m. July 10, 2014 - PR Newswire - PRF
New Board Director, Clinical Trial Results, New Drug Designations and Marketing Authorizations - Analyst Notes on Johnson & Johnson, Merck, Novartis, GSK and Endo 5:00 a.m. July 10, 2014 - PR Newswire - PRF
Fortune 500 Companies Recruit Talent at CAREERS & the disABLED Magazine's Career Expo 2:01 p.m. July 8, 2014 - PR Newswire - PRF
Kony Appoints Two Industry Luminaries to Complete Executive Team 11:00 a.m. July 8, 2014 - BusinessWire - BZX
Ortho-Clinical Diagnostics, Inc. Announces Executive Leadership Additions as It Becomes an Independent, Stand-Alone Company 8:02 a.m. July 8, 2014 - BusinessWire - BZX
Warrant Exercise Price Revisions, Acquisitions, and Maturity Extensions - Analyst Notes on JPMorgan Chase, Leju, Gramercy Property Trust, The Carlyle Group and Credit Acceptance 6:30 a.m. July 7, 2014 - PR Newswire - PRF
Major Commercial Real Estate Transaction: Liberty Park Sold and Rebranded 5:39 p.m. July 3, 2014 - Marketwire
Infusion Pumps & Accessories Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump), Application (Diabetes, Chemotherapy, Nutrition, Pain Management) & by End-user (Hospital, Home Healthcare) - Global Forecasts to 2018 4:11 p.m. July 1, 2014 - PR Newswire - PRF
India Coronary Stent Market Would Continue to Grow in Double Digits and Abbott Vascular (NYSE:ABT) to Lead the Market 2:56 p.m. July 1, 2014 - PR Newswire - PRF
Cordis Corporation Launches SABER™ PTA Dilatation Catheter toComplement Portfolio of Peripheral Arterial Disease Treatments 9:01 a.m. July 1, 2014 - BusinessWire - BZX
GlycoVaxyn announces the initiation of a Phase I clinical trial in collaboration with Janssen for a vaccine against Extra-intestinal pathogenic Escherichia coli causing urinary tract infection 2:00 a.m. July 1, 2014 - PR Newswire - PRF
Johnson & Johnson Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group 4:30 p.m. June 30, 2014 - PR Newswire - PRF
Scheduled Conference Calls, License Agreements, Dividends, Preliminary Proxy statements and Initiation of Clinical Studies - Analyst Notes on Merck, Johnson & Johnson, AbbVie, Valeant and GSK 5:20 a.m. June 30, 2014 - PR Newswire - PRF
CARE WITH PRIDE™ On Target To Deliver More Than $500K to LGBT Charities 9:30 a.m. June 25, 2014 - PR Newswire - PRF
Jennifer Doudna, Ph.D., and Emmanuelle Charpentier, Ph.D., Win 2014 Dr. Paul Janssen Award for Biomedical Research 9:30 a.m. June 24, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ReachWell Revamps Platform for Better Community Reach

Updated Category News Views 99

ReachWell's Fresh Approach: A New Era Begins Become the whisper in the wind reaching ears far and wide—enter the new ReachWell. Sounds lofty? Well, it's shooting for the stars here, folks. This isn’t just some tech upgrade. It’s a whole new brand identity and a refreshed sense of purpose. These guys have tossed everything back on the drawing board, unveiling a...

Continue Reading
OppFi's Q3 2026: Is Their Growth Strategy on Track?

Updated Category News Views 79

OppFi's Third Quarter Performance Unpacked OppFi's recent third-quarter disclosures should get investors pondering. They've launched a new line of credit product, plugging a gap in their service portfolio, and aimed to widen their customer net. Their targeted share repurchase of $6.7 million in stock isn't small potatoes either, showing a vote of confidence in their own...

Continue Reading
Regal Healthcare: Five Years of Founder-Friendly Valor

Updated Category News Views 66

Why Founder-Friendly Matters More Than Ever in Healthcare Well folks, in a year when everyone's tossing around terms like 'value-added' and 'strategic support', seeing Regal Healthcare Capital Partners snag slot number five straight on Inc.'s Founder-Friendly Investors list feels like catching a rare breed of fish twice. Seriously, these folks are stamping their forte as...

Continue Reading
FirstEnergy's New Tech to Bolster Pennsylvania Grid

Updated Category News Views 40

Electricity Demand Spurs Grid Innovation The winds of change are blowing across Pennsylvania's power grid. FirstEnergy Transmission's (NYSE:FE) subsidiary, Keystone Appalachian Transmission Company (KATCo), is diving into a significant federally funded project to reinforce grid reliability. With electricity demand on an upward trajectory, Pennsylvania and beyond need...

Continue Reading
Innovative Trial Targets Drug Resistance in Lung Cancer

Updated Category News Views 77

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Continue Reading
Royce Small-Cap Trust Shows Resilience Amid Volatility

Updated Category News Views 100

A Closer Look at Royce's Latest Moves Royce Small-Cap Trust (NYSE: RVT), the venerable old timer in the small-cap fund world, has been trucking along the market's bumpy byways since forever ago. With over 50 years of small- and micro-cap investment experience under its belt, you'd think it might have seen everything by now. But in the volatile world of small caps,...

Continue Reading
Blade and Bow Drops Rare 30-Year-Old Cask Strength Expression

Updated Category News Views 13

Turning Heads with a Rich Pour Forget watering down—Blade and Bow's latest masterpiece, the 30-Year-Old Cask Strength Kentucky Straight Bourbon Whiskey, is all about power. This new offering hasn't seen a drop of water since it left the barrel, clocking in at a punchy 164.2 proof. That's right, folks, they haven't pulled any punches this time. Heading into November,...

Continue Reading
AI Revolutionizing Hotel Revenue and Guest Engagement

Updated Category News Views 31

AI Makes Hotel Stays More Than Just a Room Ever had one of those stays where everything just clicked, and you wished you'd booked a longer visit? Well, it seems AI is turning those dreams into a reality for more folks than ever before. Canary Technologies just dropped a bombshell in the hospitality realm, showing us how artificial intelligence is reshaping the way we...

Continue Reading
ESI Motion's Role in Lockheed's Missile Defense Program

Updated Category News Views 56

ESI Motion's Solar Drive Tech Joins the Defense Arena Picture this: ESI Motion Inc. just inked a deal with Lockheed Martin to supply Solar Array Drive Electronics (SADE) technology—a serious move in space tech. Now, ESI isn't just playing in the local Simi Valley sandbox; they're thrusting their tech into something much more critical—national defense. We're talking...

Continue Reading
A&S Construction Creates Winning Culture in Louisville

Updated Category News Views 31

A&S Construction's Winning Formula: Culture Over Growth Look, in the dog-eat-dog world of construction, what really sets you apart isn't just how many roofs you stack up or the number of renovations you churn through. It's how you treat your people. And A&S Construction of Louisville gets that—ranking No. 6 in its category on the 2026 Best Places to Work list, all while...

Continue Reading

Top 5 Most Recently Viewed Articles

Ecopetrol Stock Rundown: 2023 Performance and Valuation Risks

Updated Category News Views 239

Ecopetrol's Performance: The Numbers and The Nitty-Gritty Let’s cut to the chase—Ecopetrol Inc. (NYSE:EC) is landing at about $12.78 after a modest bump of 0.87%. The last month tossed around a 3.13% dip, but hold up—year-over-year, this stock's seen a wild spike of 23.49%. However, don’t let those numbers wash over you like a smooth cup of coffee—there are some...

Continue Reading
Understanding the Recent Equity Issuance at Octopus VCT

Updated Category News Views 98

Octopus Future Generations VCT Equity Issuance Explained Octopus Future Generations VCT PLC has recently announced a significant issuance of shares that could greatly influence its investment landscape. This development marks an important milestone in the company's strategic efforts to raise capital. In an exciting update, the company has confirmed that it issued a total...

Continue Reading
Legal Action for Sarepta Therapeutics Investors Explained

Updated Category News Views 225

Understanding the Class Action Lawsuit for Sarepta Therapeutics Levi & Korsinsky, LLP is addressing significant concerns for investors in Sarepta Therapeutics, Inc. with a class action securities lawsuit. This initiative seeks to protect the interests of shareholders who may have been adversely impacted by alleged fraudulent activities related to the company's disclosures...

Continue Reading
The Booming Organic Feed Market: Future Opportunities Ahead

Updated Category News Views 224

The Growth of the Organic Feed Market The organic feed market is experiencing a significant surge, driven by an increasing demand for certified organic products. It is anticipated to reach an impressive USD 18.56 billion by 2030. This remarkable growth is propelled by changing consumer preferences and heightened awareness of health and sustainability. As more consumers...

Continue Reading
Investors Urged to Take Action with DXC Technology Group

Updated Category News Views 165

Important Actions for DXC Technology Company Investors As a shareholder of DXC Technology Company (NYSE: DXC), you may have significant stakes that deserve thorough attention, especially if your losses exceed $100,000. The Rosen Law Firm, recognized for its commitment to investor rights, encourages you to consider your options proactively. This is particularly crucial as...

Continue Reading
aria-label="Continue reading: Exploring Market Outlook for American Express (AXP) in Options Trading"> Continue Reading